
ã©ãã»ã«ã»ãã¬ã€ããã¯å士 ã¯ã¯ãã³ã«ããã¹ãã€ã¯ã¿ã³ãã¯è³ªã®è³ãžã®ãã¡ãŒãžãšçã®åå ã«ã€ããŠ
å èšäºã¯ãã¡ã/Original article here
ç±³åœã®å ç¥çµå€ç§å»ã©ãã»ã«ã»ãã¬ã€ããã¯ãChildren's Health Defenseã®ãDoctors & Scientistsãã«åºæŒããã¹ãã€ã¯ã¿ã³ãã¯è³ªã®èº«äœãžã®åœ±é¿ã«ã€ããŠè©³çްãªãã¬ãŒã³ããŒã·ã§ã³ãè¡ããŸãããç¥çµé害ãçºã¬ã³çãå¿åæ¢ãªã©ã®å¥åº·åé¡ã®æªåãšãmRNAãã¯ãããžãŒãšã®é¢é£ã«ã€ããŠãè¡æçãªçºèŠãæ«é²ããŸããã
ãã¹ãã€ã¯ã»ãããã€ã³ãšç¥çµå€æ§ããšé¡ããã圌ã®ãã¬ãŒã³ããŒã·ã§ã³ãã人工ãšããœãœãŒã ãæ³šå°ãšãã圢ã§ç¥çµç³»ã«äžãã圱é¿ããšé¡ããã¹ãã€ã¯ã¿ã³ãã¯è³ªãè³ãé«éœ¢è ãèå ã«äžãããã¡ãŒãžã«ã€ããŠåãäžããŸããã 被害ãåŒãèµ·ããã¡ã«ããºã ã詳ãã説æããããã€ãã®çºè¡šãããè«æãçšããŠãã®å®³ãå®èšŒããŠããŸãã æåŸã«ãã¯ã¯ãã³ã§è¢«å®³ãåãã人ãžã®ã¢ããã€ã¹ãããŠããã
ãããªããªãœãŒã¹ ãã«ããã³å€§åŠãªã©ã«æå±ããŠããé ã®Russell L. Blaylockæ°ã®ç ç©¶ãResearchGate
以äžã¯ãäžèšã®ãããªã«ããããã¬ã€ããã¯å士ã®çºè¡šã«åºã¥ããã®ã§ããã ã»ã¯ã·ã§ã³ã®ã¿ã€ãã«ã¯ç§ãã¡ç¬èªã®ãã®ã§ãããå 容ã¯å士ã®çºè¡šãšåãé åºã§é²ãã§ããŸããç§ãã¡ã®ã»ã¯ã·ã§ã³ã¿ã€ãã«ã¯ä»¥äžã®éãã§ãã
ãã¯ãã°ãªã¢ããµã€ãã«ã€ã³ãã±ã¢ã«ã€ã³ãèå¥®æ§æ¯çŽ
é«éœ¢è ã«ãããå ç«èå
ã¹ãã€ã¯èçœã®äžæ¢ç¥çµç³»ãžã®åœ±é¿
èå ãžã®åœ±é¿
çãåŒãèµ·ããã¡ã«ããºã
å¿èçªç¶æ»ã«ã€ããŠ
ã³ããæ³šå°ãåãã人ã¯ã©ãããã°ããã®ãïŒ
ãã¯ãã°ãªã¢ããµã€ãã«ã€ã³ãã±ã¢ã«ã€ã³ããšããµã€ãããã·ã³
ãã¹ãŠã®ã¯ã¯ãã³ã§ãç¹ã«ãã®æ³šå°ã§ã¯ãæ«æ¢¢å ç«ç³»ãåºæ¿ãããšãæ°å以å ã«è³ã®ãã¯ãã°ãªã¢ïŒè³ã®äž»èŠãªå ç«çްèïŒã掻æ§åãããã®ã§ãã ããã¯ããã¬ã€ããã¯å士ãèšããšããã® ãç æ°è¡åãã§ããã
å šèº«ã«ççãèµ·ãã£ãããäœããã®å€å·ãäœã«çããããããšãççãçããå ç«ç³»ã掻æ§åãããŸãã ãããæ°å以å ã«è³ã«ä¿¡å·ãéããè³å ã®ççæ§çŽ°èã§ãã现èå·å®³æ§çްèã§ãããã¯ãã°ãªã¢ã掻æ§åãå§ããã®ã§ãã

äžã®ç»åã¯ããã¯ãã°ãªã¢ã®ããŸããŸãªæ®µéã衚ããŠããŸãã ç»åã®äžçªäžã«ããã®ã¯éèµ·ãããã¯ãã°ãªã¢ã§ãããã¯ãæ£åžžãã§ãããåºæ¿ãåããŠããªãç¶æ ã§ãã以åã¯ãå®éæãã¯ãã°ãªã¢ããšåŒã°ããŠããŸããããããã¯æ£ç¢ºãªè¡šçŸã§ã¯ãããŸããã 仮足ã¯åžžã«äŒžã³çž®ã¿ããŠã现èå€ã®ç©ºéã«äŸµå ¥è ãããªãããååŠç©è³ªã®å«æéãå€åããŠããªãããªã©ãåæããŠãããšããã¬ã€ããã¯å士ã¯èª¬æããã

å ç«ç³»ã«åºæ¿ããããšãramified microgliaã¯primed microgliaã®æ®µéã«é²ã¿ãŸãã 仮足ãåŒã£èŸŒã¿ãããäžžã¿ã垯ã³ãå€èгã®çްèã«ãªãã ãã©ã€ãã³ã°ããããã¯ãã°ãªã¢ã®å éšã§ã¯ããµã€ãã«ã€ã³ãã±ã¢ã«ã€ã³ãè奮æ¯çŽ ã®ç£çãæ¿ããã¢ããã¬ã®ã¥ã¬ãŒããããŸãããããããããã¯çްèããæŸåºãããªãã®ã§ãå€å°ã®å ç«åå¿ã¯ãã£ãŠãããã以å€ã¯ããŸãåå¿ããæ°é ããããŸããã ããããã圌ãã ãã¯ã¯ãã³ ããšåŒã¶ãã®æ³šå°å€ã®æåã®æ³šå°ã§èµ·ããããšã§ãããšãã¬ã€ããã¯å士ã¯èšãã ã±ã¢ã«ã€ã³ããã¯ããã¡ãŒãžãã€ãŸãçœè¡çãè³ã«åŒãå¯ãããšããããšã¯éèŠãªããšã§ããã è³å ã®ãã¯ããã¡ãŒãžã¯ãã¯ãã°ãªã¢ãšãã£ããã§ããããã©ã€ãã³ã°ãåããããšãããã
ã2åç®ã®å ç«åºæ¿ïŒ2åç®ã®æ³šå°ã§ãæ°ã«æåŸã«ãªãããšãããïŒã§ã¯ããã©ã€ãã³ã°ããããã¯ãã°ãªã¢ãå®å šã«æŽ»æ§åãããŸãã ãããŠããã®æãå šãŠã®æ¯æ§æåãæŸåºãããŸããæ ¢æ§çã«æŽ»æ§åãããã¯ãã°ãªã¢ããéå°ã«æŽ»æ§åããç¶æ ã«ãªãããã¯ãã°ãªã¢ã®æŽ»æ§åã§éåžžèµ·ããããã3åãé«ãççåå¿ãèµ·ããã®ã§ãã
ãã¯ãã°ãªã¢ã2åç®ã®å ç«åºæ¿ãåããäŸãã°2åç®ã®æ³šå°ããããªãããŒã¹ã¿ãŒã®åŸã«ãé«ã¬ãã«ã®ç Žå£çèŠçŽ ãæŸåºãããšãäŸãã°æš¹ç¶çªèµ·ã现èèãããã³ã³ããªã¢ãDNAãªã©ã«æå·ãäžãããããããŠããã®ç¥çµçްèã«å€§ããªãã¡ãŒãžãäžããã®ã§ãããšãã¬ã€ããã¯å士ã¯èšãã


ææçã«ããããããããå埩ãããšããã¯ãã°ãªã¢ã¯æŽ»æ§åããç¶æ ããéèµ·ããç¶æ ã«æ»ãã éèµ·ããç¶æ ã§ã¯ãæå®³ãªååŠç©è³ªãæŸåºãã代ããã«ããã¯ãã°ãªã¢ã¯ãã¥ãŒããããã£ã³ãæŸåºããæŽ»æ§åããç¶æ ã§åãããã¡ãŒãžã修埩ããã

é«éœ¢è ã«ãããå ç«èå
é«éœ¢è ã§ã¯ãå ç«çްèã®èåãå€åãå§ãŸããå ç«çްèãèªå·±è€è£œãè¡ãããççã匷ããªãå ç«èåïŒã€ã ãã©ãã³ã°ïŒã«æ³šæããããšã倧åã§ããããã¯ãè³ãèé«ã«ããæåã®ã°ãªã¢çްèã§ãããã¯ãã°ãªã¢ãã¢ã¹ãããµã€ãã«ãèµ·ãããŸãã èåãããã¯ãã°ãªã¢ã¯ããŠã€ã«ã¹ãšæŠãèœåãäœäžããäžæ¹ã§ãççæ§ã¡ãã£ãšãŒã¿ãŒãšè奮æ¯çŽ ã倧éã«ç£çããŸãããèåããã¢ã¹ãããµã€ãã¯ãè奮æ¯çŽ ãæŒããã®ã§ããããåé¡ã«æè»ããããŠããã®ã§ããã
ããã®å šäœçãªèåã¯ã女æ§ãããç·æ§ã«èµ·ããã®ã§ãèªéçã¹ãã¯ãã©ã é害ãç¥çµå€æ§çŸæ£ã®ããã«ãç·æ§ã«åé¡ãå€ãèŠãããã®ã説æãã€ããŸããã
é«éœ¢è ã®å ç«çްèã¯ãããé«ã¬ãã«ã®ççæ§ãµã€ãã«ã€ã³ãç£çããã ãã§ãªããå埩æ§ç¥çµæ é€ååç©ã®åæ³éãããªãå°ãªããªã£ãŠããŸãããã§ããããèåãã人ã¯ãè¥ãäººã«æ¯ã¹ãŠãæ»æåŸã®åå¿ããã£ãšæªããç¥çµçްèã修埩ããèœåãäœãã®ã§ãã ããããå 霢ãç¥çµå€æ§çŸæ£ã®æå€§ã®å±éºå åã§ããçç±ã§ãããšãã¬ã€ããã¯å士ã¯è¿°ã¹ãã
ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã¯ãè³å ã ãã§ãªããå šèº«çã«ãããã®çްèãåžžã«åºæ¿ããŠããã®ã§ãå ç«èåã®ã¬ãã«ã®äžæãçã¿åºããŠããïŒãŸãã¯ãå éããŠããïŒãã
ãããŠãSucharit Bhakdiå士ãšArne Burkhardtå士ãè¡ã£ã忀ãããè³å ã®ã¹ãã€ã¯èçœãšãããåŒãèµ·ãããæå·ã瀺ãçµç¹ã¹ã©ã€ãã®ç»åã䜿ã£ãŠãBlaylockå士ã¯èª¬æããã ãã®èšäºã®åé ã«ãããããªãã¿ã€ã ã¹ã¿ã³ã17:49ãã19:19ãŸã§ãåç §ããããã
ã¹ãã€ã¯èçœã®äžæ¢ç¥çµç³»ãžã®åœ±é¿
ç ç©¶ã«ãããšãã¹ãã€ã¯èçœè³ªã¯åç¬ã§ç¥çµæ©èœãå€åããããšã®ããšã§ããã
ããç ç©¶ã§ã¯ãç ç©¶è ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã现èå ã«å ¥ãããšãã¹ãã€ã¯ã¿ã³ãã¯è³ªã ãã§ãªãã2çš®é¡ã®ãã€ã¯ãRNAãå«ãè±å¯ãªãšã¯ãœãœãŒã ã圢æãããšããã¬ã€ããã¯å士ã¯èª¬æããŠããŸãã
ããšããœãœãŒã ã«å«ãŸããã¹ãã€ã¯ã¿ã³ãã¯è³ªãããã¯ãã°ãªã¢ã®ãã€ã³ã¿ãŒãã§ãã³å¶åŸ¡ãèªå·±å¶åŸ¡ã·ã¹ãã ãIRE9ã®æ¥æ¿ãªæžå°ãåŒãèµ·ãããŠããã¯ãã°ãªã¢ã®ç Žå£åãéããªãå¢å€§ãããããšã瀺ãããã®ã§ãã
Blaylockå士ã¯ãäžèšã®ã©ã®ç ç©¶ãæããŠããã®ãæç¢ºã«ããŠããªãã ããããæã ã¯ããã«é¢é£ããå¯èœæ§ã®ããç ç©¶ãçºèŠããã
å¥ã®ç ç©¶ã§ã¯ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã®å šäœã§ã¯ãªããæçã«å¯Ÿããæäœã«ãã£ãŠãç¥çµççãèªçºãããããŠã¹ã®ãšããœãŒãèšæ¶ãæãªãããããšãçºèŠããŠããã ããã®ããšã¯ããã®æ³šå°ãåãã人éã«ãåæ§ã«èŠãããããšã§ã圌ãã¯èšæ¶é害ãèµ·ãããŠããŸãããšããã¬ã€ããã¯å士ã¯è¿°ã¹ãŠããŸãã
ãè³ã«ã¯ãα-7ãã³ãã³æ§ã¢ã»ãã«ã³ãªã³å容äœãšåŒã°ãããç¹å¥ãªæççã·ã¹ãã ãçµã¿èŸŒãŸããŠããŠãããããå šãŠã®ççåå¿ãããŠã³ã¬ã®ã¥ã¬ãŒãããŠãããã®ã§ãã ãŸããèšæ¶ãšåŠç¿ã«ãé¢äžããŠããŸãã ããã§ãã¹ãã€ã¯ã¿ã³ãã¯è³ªãå ç«ãããšããããã®æçã ãã§ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã«å¯Ÿããå ç«åå¿ãèµ·ããããã®åç©ã§ã¯ãšããœãŒãèšæ¶ã倱ãããŠããããšãããããŸããã 2åç®ã®æ³šå°ã¯ããã«æªåããŸããã ããã¯ãæã ãè°è«ãããã©ã€ãã³ã°å¹æã蚌æãããã®ã§ãã2åç®ã®æ³šå°ã¯ãã€ãæªããªãã®ã§ãã
ããã³ã³ããªã¢å¹æã«ã€ããŠã®ç ç©¶ã§ã¯ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã¯ãåç¬ã§ãéåžžã«é«ãã¬ãã«ã®æŽ»æ§é žçŽ ãšæŽ»æ§çªçŽ çš®ãçæãããã¯ãã°ãªã¢ã®ããã³ã³ããªã¢æŽ»æ§ãå¢å ãããããšã瀺ãããŸããã ããã«ãã£ãŠããã¯ãã°ãªã¢ã¯éåžžãããç Žå£çã«ãªãããšãã¬ã€ããã¯å士ã¯èª¬æããã ãã®ç ç©¶ã§ã¯ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã«ãããããããã³ã³ããªã¢ã®ååŠç©è³ªãåºç¯å²ã«ããã£ãŠå€åããŠããããšãããã£ãã ã±ã¢ã«ã€ã³ããµã€ãã«ã€ã³ãå¢å ããŠããããšã«æ°ã¥ããã®ã§ããããŸããã¹ãã€ã¯ã¿ã³ãã¯è³ªãæäžãããšããã¯ãã°ãªã¢ã®ACE2å容äœçµåéšäœã50ïŒ å¢å ãããã€ãŸããã¹ãã€ã¯ã¿ã³ãã¯è³ªã®åœ±é¿ãåãããã¯ãã°ãªã¢ãããå€ãååšããããšã«ãªãã å šäœãšããŠã现èå ã®äž»èŠãªççæ§æåã§ããã€ã³ãã©ããœãŒã ã64%å¢å ããããšãããã£ãããŸããã¹ãã€ã¯ã¿ã³ãã¯ã¯ãè³ãççã«èããèœåãæãªããè³å ãµã€ãã«ã€ã³ã®åµã倧ããä¿é²ãããããšãæããã«ãªã£ãã
ã¹ãã€ã¯ã¿ã³ãã¯è³ªã®ããã³ã³ããªã¢ãžã®åœ±é¿ã«é¢ãã2ã€ç®ã®ç ç©¶ã§ã¯ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã«ãã£ãŠãã¯ãã°ãªã¢ãè§£ç³ã«åãæ¿ãããããã¯ãããè¡ãããšã§ããããšãããããŸããã è§£ç³ã¯ãççãšèå¥®æ¯æ§ãå¢å€§ãããã
3æã«çºè¡šãããç ç©¶ã§ã¯ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã®æçã§ããS1ãµããŠããããããŠã¹ã®æµ·éŠ¬ã«æ³šå ¥ãããæµ·éЬã¯ãäž»ã«èšæ¶ãšé¢é£ããè³ã®é åã§ããã ã圌ãã¯æ·±ãèªç¥é害ãçºèŠããã®ã§ãããšãã¬ã€ããã¯å士ã¯èªã£ããåŠç¿ã»èšæ¶ãšææ ã«é¢ããè³ã®2ã€ã®ãŸãŒã³ã§ãç¥çµçްèãèããæžå°ããã¢ã¹ãããµã€ãã®æŽ»æ§åã59ïŒ ïœ63ïŒ å¢å ããŠããããšãããã£ãã®ã§ãã ç ç©¶è ãã¯ãç¥çµçްèã®æ»ã¯ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã«ãã£ãŠåŒãèµ·ãããããã¯ãã°ãªã¢ã®æŽ»æ§åã«ãã£ãŠåŒãèµ·ããããäºæ¬¡çãªãã®ã§ãããšå€æããŸããã ãã€ãŸããS1ãã©ã°ã¡ã³ãã ãã§ãé床ã®èªç¥é害ãåŒãèµ·ããå¯èœæ§ããããšããããšã§ãããšããã¬ã€ããã¯å士ã¯è¿°ã¹ãŠããã
Blaylockå士ã«ããã°ãã¹ãã€ã¯èçœè³ªã¯è³å¹¹ã®å§å容åšã®æåºŠãäœäžãããããšãåãã£ãŠãããšã®ããšã§ããã è³å¹¹ã¯å¿ææ°ãã³ã³ãããŒã«ãããšããã§ããã ããã®æ³šå°ã«ãã£ãŠäœäœæ§é »èçå矀ãå€ãèŠãããããããã¯ã¹ãã€ã¯èçœãå§å容åšã«åœ±é¿ãåãŒãããã§ãããçã«ããªã£ãŠããããšBlaylockå士ã¯è¿°ã¹ããPOTSãšã¯postural orthostatic tachycardia syndromeã®é æåããšã£ããã®ã§ããã
ã¹ãã€ã¯èçœã¯å ç®çްèã«å ¥ããæ¥éã«æ žã«å ¥ã蟌ãããšãããã£ãŠããã ãŸããå ç®çްèã®ããã³ã³ããªã¢ãæå·ããã ã©ã¡ãããè¡ç®¡ã®æ©èœã«äžå¯æ¬ ãªå ç®çްèã®æ©èœãäœäžãããäœçšãããã ç¹ã«å ç®çްèã¯ãè¡æ¶²è³é¢éã«éèŠãªåœ¹å²ãæãããŠããã å ç®çްèã®æ©èœãäœäžãããšãè³ã®åèã现åèãæ¯çŽ°è¡ç®¡ã«é害ãçºçããŸãããããã®è¡ç®¡ã®æå·ã¯è³åäžã«ã€ãªããããã¬ã€ããã¯å士ã¯ããæéãçµã€ã«ã€ããŠããŸã å ±åãããŠããŸããããåèç€ãããããã§ããã®ã§ã¯ãªãããšæããŸããããšè¿°ã¹ãããããã¯ãè¡ç®¡å£ã®å®å šæ§ãæãªãããŠããããã§ããããåèç€ãªã®ã§ããã
ã¹ãã€ã¯ã¿ã³ãã¯è³ªã®å€ç°ã¯ã2011幎ã«çºè¡šãããç ç©¶ã§ããèå¥®æ¯æ§ãèªçºããããšã瀺ãããŠããŸãã ãã®ç ç©¶ã¯ãSARS-CoV-2ãšã¯ç°ãªãã³ãããŠã€ã«ã¹ã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªãçšãããã®ã§ãããã¹ãã€ã¯ã¿ã³ãã¯è³ªãåŒãèµ·ãããã¡ãŒãžã瀺ãããŠããŸãã
ç¥çµåŠçãªåœ±é¿ãããããšãåãã£ãŠããããMRIã¹ãã£ã³ãæ£åžžã§ãã£ã6äººã®æ£è ã察象ã«ãæ¡æ£ãã³ãœã«ç»åïŒDTIïŒã¹ãã£ã³ãè¡ãããŸããã DTIã¯çœè³ªå ã®è»žçŽ¢ã®æå·ã瀺ããç ç©¶è ãçœè³ªã®åã ã®ç¹ç¶ãèŠãããšãå¯èœã«ããŸããçœè³ªã¯ãç¥çµç·ç¶ãããªãè³å ã®çµç¹ã§ãã軞玢ãšåŒã°ããç¥çµç·ç¶ã¯ãç¥çµçްèå士ãã€ãªããèèªã®äžçš®ã§ããããšãªã³ã«èŠãããŠããŸããçœè³ªãçœãã®ã¯ããã®ããšãªã³ã®ãããã§ãã ãã®ç ç©¶ã§ã¯ã6人ã®åå è å šå¡ã«ãççã瀺ãDTIã¹ãã£ã³ã«ç°åžžãèŠãããã 被éšè ã®1äººãæ»äº¡ããæ»åŸè§£åãè¡ããããšãããç¹ã«è³å¹¹ã§ãã¯ãã°ãªã¢ãåºç¯å²ã«ããã£ãп޻æ§åããŠããããšã倿ããã ä»ã®ç ç©¶ã§ãããã¯ãã°ãªã¢æŽ»æ§ã¯çœè³ªã§æãæ¿ãããç°çœè³ªã§ã¯èŠãããªãããšã確èªãããŠããã
çœè³ªã«ã¯ãè³ã®ãã¹ãŠã®é åãã€ãªãç·ç¶ããããŸãã ã§ãããããã®ç¹ç¶ãæå·ãããšãç°çœè³ªã¯ã³ãã¥ãã±ãŒã·ã§ã³ããšããªããªããåããªããªããŸãã ãããèªéçã§èµ·ããããšã§ãããçœè³ªç°åžžã¯èªéçã®äººã«èŠãããã
èå ãžã®åœ±é¿
çºè²äžã®èå ã«åãŒã圱é¿ã¯ãé©ãã¹ããã®ã§ãã
ãããè質ãã£ãªã¢ã¯ãèç€ãééããŠãèµ€ã¡ããã®è¡æ¶²åŸªç°ã«å ¥ãããã¡ãããæåã«è¿°ã¹ãããã«ãåäŸã¯æ¯å25äžåã®è³çްèãã€ããŠããã®ã§ãè³ã®çºéãæãªãããŸããããã«ãèå¥®æ¯æ§ãççãèµ·ãã£ãŠããã®ã§ãããšãã¬ã€ããã¯å士ã¯èšãã
äŸãã°ãæäººã®èªéçã調ã¹ããšããã40幎åŸã§ããã¯ãã°ãªã¢ã¯æŽ»æ§åããŠããã Blaylockå士ã¯ããèŠåããŠããã
ãã³ããæ³šå ¥ã®çµæãšããŠæã ã¯ãã¹ãŠãèŠãããšã«ãªããšæãã èªéçã¹ãã¯ãã©ã ãé©ç°çã«å¢å ããã§ãããã ããäžã€ã¯ã粟ç¥åè£ç ã§ããã åŠåš 3ã¶æç®ã«å ç«ç³»ãåºæ¿ãããšã粟ç¥åè£ç ã®çºççã6åã«ãªãããšãåãã£ãŠããŸãã ããããããã¯ææ¥æã«ãªã£ãŠããçºçãããã®ã§ãç§ãã¡ããããç®ã«ããããã«ãªãã«ã¯ãé·ãæéãå¿ èŠã§ããã
ãããããå¥åœ¢ã¯ãã§ã«300ã400ïŒ å¢å ããŠããŸãããæµç£ãªã©ããã¹ãŠãä»ãŸã§èŠãããšã®ãªããã®ã«ãªããšæããŸãã ããããã¹ãŠã®æ²åãªã®ã§ãã
å°å ç§ã®çµç¹ãã³ããæ³šå°ãæšå¥šããŠããã®ã¯ããšãã§ããªãããšã§ãã
ãããåŒãèµ·ããã¡ã«ããºã
ã©ã€ã¢ã³ã»ã³ãŒã«å士ã¯ãç¶¿å¯ãªèšé²ããšããã³ããæ³šå°ã®æ®ååŸã«æ»æçãªãããéåžžã«å¢ããŠããããšã«æ°ã¥ããŸããã ãŸãããããããŸãã³ã³ãããŒã«ããŠãã人ãã¡ããã³ã³ãããŒã«ã§ããªããããçºçããéåžžã«æ©ãæ»äº¡ããŠããããšã«ãæ°ã¥ããŸããã
ã³ããæ³šå ¥åŸã¯ããããšéãããã®ãªã³ãçãäœäžããŠããããããåå ãšããŠããèªãããããšã§ãã ããããä»ã«äºã€ã®ã¡ã«ããºã ããããã®ã¬ã³ãåŒãèµ·ããã®ã§ãããã調ã¹ãå¿ èŠãããããšãã¬ã€ããã¯å士ã¯èšãã äžã€ã¯çºçæ§ãŠã€ã«ã¹ã®æŽ»æ§åã§ãããããäžã€ã¯ã°ã«ã¿ãã³é žã®ã¬ãã«ã§ããã
çºããæ§ãŠã€ã«ã¹
ã³ããæ³šå°ãæœäŒãŠã€ã«ã¹ã掻æ§åãããŠããããšã¯ãäœåºŠãèšåãããŠããã ãçºçæ§ãŠã£ã«ã¹ã¯ããããããããšãã¬ã€ããã¯å士ãèšã£ãã

ãããã®ãŠã€ã«ã¹ã®1ã€ã掻æ§åãããšã匷åãªãªã³ã³ã¢ãžã¥ã¬ãŒã¿ãŒãšãªããçã®èªçºãšå¢åŒ·ã®ã¡ã«ããºã ã®1ã€ã¯ççã§ããã ççã¯ãäºå®äžãã¹ãŠã®çã®äž»èŠãªåå ã§ããããšãç¥ãããŠãããããããã¹ããŒãžã§çãå¢å ããããšããã¬ã€ããã¯å士ã¯è¿°ã¹ãŠããŸãã
ããããã®æ³šå°ã®ããã«ãççã®çšåºŠãšé·æã®æ§è³ªãããããã¯ã¯ãã³ã¯ç¥ãããŠããªãã ãããŠãããã¯ç¶ç¶çã§ã圌ãã¯ãåžžã«ã¹ãã€ã¯ã¿ã³ãã¯è³ªã®éãå¢ããç¶ããŠããŸããã
ã°ã«ã¿ãã³é ž
ãã¹ãŠã®å ç«çްèã¯ã°ã«ã¿ãã³é žãåæ³ããŸãã ã§ããããå ç«ç³»ã掻æ§åããŠçµç¹ã«æµžæœ€ãããšããã®çµç¹ã®ã°ã«ã¿ãã³é žã¬ãã«ãããªãäžæããã®ã§ããããã€ãã®çã¯ãã°ã«ã¿ãã³é žã«ãã£ãŠåºæ¿ãããããšãç¥ãããŠããã ã°ã«ã¿ãã³é žé®æè¬ã¯ã现èåè£ãæããçŽ°èæ»ãå¢å ããã现èç§»åãé»å®³ããããšã瀺ãããŠããŸãã
ã°ã«ã¿ãã³é žå容äœã¯äœäžã«ååšããŸãã

è³å ã®ãã¯ãã°ãªã¢ã®æµžæœ€ã¯ãã°ã«ã¿ãã³é žãåæ³ãã现èã«ããæµžæœ€ãšåæ§ã«è³è «çã®æé·ãä¿é²ããããåçºæ§è³è «çã¯ç¹ã«ãã®åŸåã匷ãããšBlaylockå士ã¯èª¬æããã å€åœ¢æ§è èœè «ã®å Žåãè «çå ã®ã°ã«ã¿ãã³é žæ¿åºŠãéåžžã«é«ã人ã¯ãäºåŸãéåžžã«æªãã ã°ã«ã¿ãã³é žãéåžžã«å°ãªã人ã¯ããã£ãšé·çãããããã§ãã
å¿èçªç¶æ»
ãå¿èçªç¶æ»ã泚å°ã«ãã£ãŠåŒãèµ·ããããããšãé ãããšãã人ã ã¯ãçªç¶æ»çå矀ãšåŒãã§ããŸãããããã¯ãã³ã»ã³ã¹ãªèšèã§ãããšãã¬ã€ããã¯å士ã¯èšã£ãã
å¿èã®ãã¹ãŠã®çµç¹ã«ã¯ã°ã«ã¿ãã³é žã®å容äœããããå¿èã®é»æ°äŒå°ç³»ã¯ãã¹ãŠã°ã«ã¿ãã³é žå容äœã«ãã£ãŠå¶åŸ¡ãããŠããã ããããŠãçµç¹ãã°ãã·ãŠã ãäœã人ã¯è奮æ¯çŽ ã®ã¬ãã«ãé«ããå¿èçªç¶æ»ãèµ·ãããããããšãåãã£ãŠããŸãããšèª¬æããã
ãŸããå¿èã¯è³å¹¹ã«ããäžæ¢ç¥çµç³»ã«ãã£ãŠãå¿èã®åçž®ããªãºã ãå¶åŸ¡ãããŠããã è³å¹¹ã§ã°ã«ã¿ãã³é žãéå°ã«ãªããšãäžæŽèãäžæŽèãå¿èçªç¶æ»ãå¿çæ¢å¡ãåŒãèµ·ããå¯èœæ§ããããšããã
åç©å®éšã§ã¯ããã ã¹ã¿ãŒã«ã°ã«ã¿ãã³é žããããã¯ããååç©ã5æ¥éæäžããŸããã ãã®ãã ã¹ã¿ãŒã¯ãéºäŒçã«ã¹ãã¬ã¹ã«ããããããšå¿èãçªç¶æ»ããæ§è³ªããããŸãããã°ã«ã¿ãã³é žååç©ãæäžãããšãããã¹ãã¬ã¹ã«ããæ»äº¡ãææã«æžå°ããã ããããäœãã°ãã·ãŠã é£ãäžããåŸãã¹ãã¬ã¹ã«ãããããåç©ã¯ãã¹ãŠæ»äº¡ããã ãã°ãã·ãŠã æ¿åºŠãäžããåç©ã§ã¯ãäžå¹ãæ»ãªãªãã£ãã®ã§ãããã€ãŸããäœãã°ãã·ãŠã ã¯ã»ã»ã»èå¥®æ¯æ§ã倧ãã«é«ããã®ã§ãããšããã¬ã€ããã¯å士ã¯èšãã
å€ãã®äººããå å·¥é£åãã¢ã¹ãã«ããŒã ã«å«ãŸããã°ã«ã¿ãã³é žãå€ãå«ãé£äºãããŠããäžæ¹ã§ããã°ãã·ãŠã ã®è²¯èµéãå°ãªãããããå¿èçªç¶æ»ã®åŒãéã«ãªãããšããããŸãã ãã€ãŸããããªãããã®ã«ããŽãªãŒã«å±ãããã®æ³šå°ãåããå Žåããããããããåå ã§æ»ã¬ããšã«ãªãã®ã¯ããããã§ãããããšBlaylockå士ã¯èª¬æããã
ã³ããæ³šå°ãåãã人ã¯ã©ãããã°ããã®ã§ããïŒ
ãã¬ã€ããã¯å士ã¯ãè¬æŒã®æåŸã«ãç¹ã«ã¯ã¯ãã³ã§å·å®³ãåãã人ãžã®ã¢ããã€ã¹ãè¿°ã¹ãŸããã 圌ã¯ããèšã£ãã
ããã¯ãã°ãªã¢ãéãã«ããããã ãã®ä¿è·ã·ã¹ãã ã確ç«ããæå©ãããããã®ã§ãã ããã¯ãã¯ã«ã¯ãã³ã®ãããªå€ãã®ååç©ã§å¯èœã§ããã±ã«ã»ãã³ããã»ãã³ããã¹ããªãžã³ããã¿ãã³D3ããã¿ãã³Cãªã©ãæ°ãäžããã°ããããªãã»ã©ã§ãã ãã©ããã€ãã«ã¯ããã¯ãã°ãªã¢ãæ²éåããã广ãããããšãç¥ãããŠãããã®ããããããããŸãã ã·ãªããªã³ã¯ãããããããªæ¿åºŠã§ãããå®çŸããŸããã
ãåé¡ã¯ãæ¶å管ã«åžåãããããšã§ãããããã®ååç©ã«ã¯ãåžåçãé«ãã髿¿åºŠã§è³ã«å ¥ããããã©ãŒã ãããã®ã§ããããå©çšããã®ã§ãã ããã¯ã«ã¯ãã³ã詊ããŠã¿ãããšããå§ãããŸããã
ããŸããããã³ã³ããªã¢æ©èœãé«ããããšãéèŠã§ãã ããã³ã³ããªã¢æ©èœãé«ããããã«ãããŸããŸãªååç©ã䜿çšããããšãã§ããŸããã
ããããŠãèå¥®æ¯æ§ãåŒãèµ·ãããã¡ãŒãžã軜æžããããã«ãå šãŠã®æé žåç©è³ªãå¿ èŠã§ããã
泚å°ã«ããããã¯ãã©ãããã°ããã®ã§ããïŒ
ãã¬ã€ããã¯å士ã¯ããããæ£è ã®ããã®ããã¥ã©ã«ã»ã¹ãã©ããžãŒããšããèªç¶ãªããæ²»çã«é¢ããæ¬ãæžããŠããã®ã§ããã®ããŒãã«ã€ããŠå¹ åºãç ç©¶ããŠããã®ã§ãã
ãéåžžã«åŒ·åãªçæå¶å€ãšãªã倩ç¶ååç©ããããããããŸãã å¿ èŠãªã®ã¯ããªã³ãçãäžããããšã§ãã ããã ã®ã¯çæ£è ã®ãªã³ãçãåçã«äžæãããŸããã
ããããŠãç§ã¯äœäººãã®çæ£è ã«ãããè¡ãã圌ãã®ãªã³ãçãæ£åžžã«æ»ããçãã³ã³ãããŒã«ãããããšããããŸã ã¹ããŒãž4ã®ä¹³çã®å¥³æ§ãäœäººãé£ããŠããŸããããããããè¡ã£ããšããã圌ãã¯é·ãçåæéãåŸãŠãã»ãšãã©ã®äººãä»ãçããŠããŸãã ã€ãŸããããã¯å¹æããããã§ããã
ãããããä»ã®æä»£å šãŠã«èšããããšã§ããã圌ãã¯ãããé èœããŠããŸãã 補è¬äŒç€Ÿã¯ã人ã ãå©çšããŠå€§éã皌ãã®ã§ãããªãã«ç¥ã£ãŠæ¬²ãããããŸãããã
ãããªããªãœãŒã¹
ã¯ã«ã¯ãã³ãããã®å¥åº·ãé£åãžã®åœ±é¿ã«é¢ããã¬ãã¥ãŒ 2017幎10æ22æ¥
GreenMedInfoã«ã¯ã«ã¯ãã³ãæ²èŒãããŸããã
GreenMedInfoã«æ²èŒãããã±ã«ã»ãã³
GreenMedInfoã§ãã¹ããªãžã³
GreenMedInfoã§ã¢ã¹ãã©ã¬ã«ã¹